Call for Papers: ASSAY and Drug Development Technologies.

Abstract

ASSAY and Drug Development TechnologiesVol. 18, No. 4 Calls for PapersFree AccessCall for Papers: ASSAY and Drug Development TechnologiesEditor-in-Chief: Bruce MelanconEditor-in-Chief: Bruce MelanconVanderbilt Center for Neuroscience Drug Discovery, Franklin, TN, USASearch for more papers by this authorPublished Online:21 May 2020https://doi.org/10.1089/adt.2019.29090.cfp6AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail ASSAY and Drug Development Technologies focuses on early-stage screening techniques and tools that optimize the identification of novel leads and targets for new drug development, running the spectrum from nanotechnology through cellular imaging. Case studies are presented, and technology applications are extensive. Articles published in the Journal emphasize methodologies and technologies to accelerate drug discovery.Benefits of submitting include:♦ Fast and user-friendly electronic submission♦ Rapid peer review and publication♦ A diversity of article types♦ Maximum exposure: readership in more than 170 countries worldwide♦ Competitive Author Benefits Program♦ Open access options availableFor complete author instructions and to submit your manuscript, please visit: liebertpub.com/manuscript/adtFiguresReferencesRelatedDetails Volume 18Issue 4May 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Editor-in-Chief: Bruce Melancon.Call for Papers: ASSAY and Drug Development Technologies.ASSAY and Drug Development Technologies.May 2020.156-156.http://doi.org/10.1089/adt.2019.29090.cfp6Published in Volume: 18 Issue 4: May 21, 2020Online Ahead of Print:April 20, 2020PDF download